IL29 Antikörper (AA 21-200) (FITC)
Kurzübersicht für IL29 Antikörper (AA 21-200) (FITC) (ABIN7156610)
Target
Alle IL29 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - AA 21-200
 - 
                                            
Kreuzreaktivität
 - Human
 - 
                                            
Aufreinigung
 - >95%, Protein G purified
 - 
                                            
Immunogen
 - Recombinant Human Interferon lambda-1 protein (21-200AA)
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - 
                        Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 
                                            
Konservierungsmittel
 - ProClin
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - -20 °C,-80 °C
 - 
                                            
Informationen zur Lagerung
 - Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
 - 
                                            
 - 
    
- IL29 (Interleukin 29 (IL29))
 - 
                                            
Andere Bezeichnung
 - IFNL1
 - 
                                            
Hintergrund
 - 
                        
Background: Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression.
Aliases: IFNL1 antibody, IL29 antibody, ZCYTO21Interferon lambda-1 antibody, IFN-lambda-1 antibody, Cytokine Zcyto21 antibody, Interleukin-29 antibody, IL-29 antibody
 - 
                                            
UniProt
 - Q8IU54
 
Target
 -